Intelligence · Clinical Development
Pipeline search results
Programs matching “advanced-solid-tumors” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 61 pipeline programs matching "advanced-solid-tumors" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BGM-2121
Chongqing Precision Biotech Co., Ltd
Advanced Solid Tumors
1 trial -
BPT567
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
CHR-2797 (tosedostat)
United Therapeutics Europe Ltd
Advanced Solid Tumors
1 trial -
CT053PTSA
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Solid Tumors
1 trial -
Cabiralizumab
Prime Medicine
Advanced Solid Tumors
1 trial -
Evixapodlin
Gilead Sciences Ireland UC
Advanced Solid Tumors
1 trial -
FPA144
Prime Medicine
Advanced Solid Tumors
1 trial -
FPT155
Prime Medicine
Advanced Solid Tumors
1 trial -
FT500
Zafatek
Advanced Solid Tumors
1 trial -
GK01 Injection
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
HBT-708
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Solid Tumors
1 trial -
HRS-2329 Tablet
Jian Li
Advanced Solid Tumors Harboring RAS Mutations or Amplifications
1 trial -
HW071021 Tablets
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
HW071021 Tablets
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Advanced Solid Tumors
1 trial -
HWS116 Injection
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
ION537
IONIS PHARMACEUTICALS INC
Advanced Solid Tumors
1 trial -
IXAZOMIB
Takeda
Advanced Solid Tumors
1 trial -
KXV01 TCR Lentinvivo Injection
TScan Therapeutics
Advanced Solid Tumors
2 trials -
KXV01 TCR Lentinvivo Injection
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Lenalidomide (CC-5013)
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
Lipotecan
Taiwan Liposome Company
Advanced Solid Tumors
1 trial -
MLN4924
Takeda
Advanced Solid Tumors
1 trial -
Niraparib
Takeda
Advanced Solid Tumors
1 trial -
OKI-179
OnKure Therapeutics
Advanced Solid Tumors
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.